Skip to main content

Triamterene and Hydrochlorothiazide

NDC 82868-006 · Northwind Health Company, LLC

Generic nameTriamterene and Hydrochlorothiazide
Dosage formTABLET
RouteORAL
Active ingredient(s)TRIAMTERENE, HYDROCHLOROTHIAZIDE
Strength25; 37.5 mg/1; mg/1
Pharmacologic classDecreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

82868-006-30 — 30 TABLET in 1 BOTTLE, PLASTIC (82868-006-30)

82868-006-90 — 90 TABLET in 1 BOTTLE, PLASTIC (82868-006-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

78206-139 — losartan potassium and hydrochlorothiazide, 78206-140 — losartan potassium and hydrochlorothiazide, 78206-141 — losartan potassium and hydrochlorothiazide, 80425-0207 — Lisinopril and Hydrochlorothiazide, 82804-031 — Hydrochlorothiazide, 82804-103 — losartan potassium and hydrochlorothiazide, 82804-239 — losartan potassium and hydrochlorothiazide, 82804-307 — Lisinopril and Hydrochlorothiazide Tablets, 82804-308 — Triamterene and Hydrochlorothiazide, 82804-972 — Hydrochlorothiazide, 82804-973 — Hydrochlorothiazide, 82868-016 — hydrochlorothiazide, 82868-022 — Triamterene and Hydrochlorothiazide, 82868-032 — Triamterene and Hydrochlorothiazide, 82868-054 — Valsartan and Hydrochlorothiazide, 83008-086 — losartan potassium and hydrochlorothiazide, 84677-056 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 84677-057 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 84677-058 — OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE, 87441-038 — Hydrochlorothiazide, +863 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels